As the position evolves, CXOs are taking on more responsibility. Today’s CXO must expand beyond the patient to include customers, or people who haven’t yet interacted with a healthcare organization but may have a desire to do so. Edwards explains that the CXO also has to focus on how to…
Source: healthtechmagazine.net – Read more
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
